Ascendia

  MARKET NEWS

Hovione Unveils New Continuous Tableting Line at Lisbon R&D Centre
CoreRx Completes Acquisition of Societal CDMO
Skinvisible Expands Obesity Patent Application for Transdermal Delivery
BioNTech & DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate in Prostate Cancer
TFF Pharmaceuticals Provides Regulatory Update on Tacrolimus Inhalation Powder Clinical Program for the Prevention of Lung Transplant Rejection
Checkpoint Therapeutics Announces Alignment With FDA Enabling Upcoming Cosibelimab BLA Resubmission
4DMT Announces FDA Clearance of IND Application for Genetic Medicine for the Treatment of Geographic Atrophy
IMUNON Announces Database Lock for Phase 2 OVATION 2 Study With IMNN-001 in Advanced Ovarian Cancer
Bio-Rad Extends Range of Anti-Biotherapeutic Antibodies to Accelerate Antibody Drug Development
Abzena & Argonaut Partner to Offer Fully Integrated Drug Substance & Drug Product Solution

  EXPERT CONTENT & RESOURCES

How AbbVie Operations & Contract Manufacturing Has Prepared Global Parenteral Sites for the Annex 1 Compliance Requirement

How AbbVie Operations & Contract Manufacturing Has Prepared Global Parenteral Sites for the Annex 1 Compliance Requirement

This article explains the key changes that pharmaceutical companies and CMOs engaged in manufacturing and fill-finish need to consider, as well as what AbbVie Contract Manufacturing (AbbVie CMO) is doing to ensure its global operations and aseptic fill-finish sites are in compliance with the revised regulations….

Lyophilization Trends in Pharma & Biopharma Drug Development

Lyophilization Trends in Pharma & Biopharma Drug Development

This 30-page eBook is exactly what you have been looking for. Find out what is driving the lyophilization market and how working with a CDMO will save time and money and help you comply with increasing regulatory requirements.

Premium Cell Culture Ingredients From Actylis

Premium Cell Culture Ingredients From Actylis

Thanks to our many GMP manufacturing sites located in North America, Europe and Asia we can provide the critical ingredients for your Biopharma manufacturing applications.

  FEATURED EDITORIAL

  COMPANY PROFILE

Agno Pharmaceuticals is a leading, global, small molecule Contract Development and Manufacturing Organization (CDMO), catering to the specific needs of the branded pharmaceutical, biotech, generic, and CDMO sectors. Agno Pharmaceuticals is a US-based, end-to-end premier service provider. We specialize in supplying Registered Starting Materials (RSMs), custom Chemical Intermediates, Active Pharmaceutical Ingredients (APIs), highly potent APIs, sterile APIs, and complex Drug Product formulations (including long-acting injectables/implants) to our valued clientele worldwide. Our US-FDA inspected cGMP compliant manufacturing facilities ensures that we are able to provide our services at a level of unparalleled quality and compliance to our customer base. Click here for more.

  WHITEPAPERS & WEBINARS


WHITEPAPER - Case Study-Improving Bioavailability Using PBPK Modeling & Parallel Formulation Screening

WHITEPAPER - Case Study-Improving Bioavailability Using PBPK Modeling & Parallel Formulation Screening

Abstract: A team of bioavailability experts at Catalent used the in-house bioavailability enhancement platform, OptiForm® Solution Suite, to optimize and develop Phase 1 clinical formulation within a short timeline. Catalent’s global supply chain expertise was utilized for packaging and distributing …

WHITEPAPER - Purity is Paramount: Assessing N-Oxide Impurities in Lipids Used in Lipid Nanoparticle Delivery Systems

WHITEPAPER - Purity is Paramount: Assessing N-Oxide Impurities in Lipids Used in Lipid Nanoparticle Delivery Systems

By: Sabrina Metze, PhD, Ulrich Klöckner, PhD, Lars Geiger, PhD, Justin Schieven, PhD, and Thomas Böhmer*

Summary

The quality of lipids in a lipid nanoparticle assembly is critically important to the functionality of mRNA-based therapeutics. Packer et al. have identified …

WHITEPAPER - Manufacturing of 10-mg Loratadine Self-Emulsifying Drug Delivery System (SEDDS) Tablets by Direct Compression With ABISORB-DC & ABISOL Emulsion Preconcentrate Kit

WHITEPAPER - Manufacturing of 10-mg Loratadine Self-Emulsifying Drug Delivery System (SEDDS) Tablets by Direct Compression With ABISORB-DC & ABISOL Emulsion Preconcentrate Kit

Traditionally, lipid-based drug delivery, including SEDDS, for per-oral dosing have primarily been formulated as soft-gels or liquid-filled hard-gels. With ABISORB-DC, the bioavailability enhancing features of lipid-based drug delivery can be combined with the high-throughput and ease of manufacturing of direct …

WHITEPAPER - Efficient Development of Miniature Drug-Loaded Implants

WHITEPAPER - Efficient Development of Miniature Drug-Loaded Implants

Drug-eluting implants offer a unique approach to overcoming challenges associated with traditional drug delivery methods. They can provide sustained, continuous release of a therapeutic at the desired site of action.

Download our latest white paper, jointly authored with MeltPrep, to …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

July 3 – Controlled Release
July 10 – Analytical Testing